Vatican Welcomes Two Vienna BioCenter Scientists
en-GBde-DEes-ESfr-FR

Vatican Welcomes Two Vienna BioCenter Scientists


The Pontifical Academy of Sciences, an independent and non-sectarian group, invited 20 of the most visible stem cell biologists in the world to the Vatican. Jürgen Knoblich, Scientific Director, Institute of Molecular Biotechnology, was among them. Knoblich is regarded as the first scientist in Austria to use human embryonic stem cells. Knoblich was joined by Senior Scientist Elly Tanaka, Institute of Molecular Pathology.

The “Workshop on Stem Cells and Their Promise for Regenerative Medicine” highlighted the importance of ethical debates in the field of stem cell research and the willingness and interest of scientists to engage in ethical discussions. The attending scientists discussed stem cell therapies in the fields of macular degeneration, skin therapies, and Parkinson’s disease amongst other topics. In a nod to the success of the fields, Knoblich called some of these therapies very close to clinical trials.

At the meeting, Knoblich described the use of stem cells in model systems as an advanced tool for regenerative medicine. More specifically, he communicated his research on brain organoids and enunciated their value in modeling disease. In its conference booklet, the Academy stated some cultured organoids “may replace organ transplants from donors and open the way to regenerative medicine.”

Knoblich summarized his thoughts about the meeting in the following way, “In a time where the medical application of stem cells becomes a reality, we should not forget to continue nurturing curiosity-driven research to lay the ground for curing the incurable and for the future development of therapies that seem unthinkable now.”

A review of Knoblich’s work will be published as part of a book from the Vatican. Knoblich has been a member of The Pontifical Academy of Sciences, an academic organization that advises the Vatican and is independent from the jurisdiction of the Vatican since August 18, 2020. The Annual Assembly of the Academy convenes in September, where he will meet Pope Francis and be formally inducted. Visit the Academy’s website for more information about Knoblich’s membership.

IMBA Scientific Director Jürgen Knoblich is also Professor in Synthetic Biology at the Medical University of Vienna.

About IMBA
IMBA - Institute of Molecular Biotechnology - is one of the leading biomedical research institutes in Europe focusing on cutting-edge stem cell technologies, functional genomics, and RNA biology. IMBA is located at the Vienna BioCenter, the vibrant cluster of universities, research institutes and biotech companies in Austria. IMBA is a subsidiary of the Austrian Academy of Sciences, the leading national sponsor of non-university academic research. The stem cell and organoid research at IMBA is being funded by the Austrian Federal Ministry of Science and the City of Vienna.
Attached files
  • Academicians of the Pontifical Academy of Sciences and Vatican Cardinals attend the stem cell conference at Casina Pio IV, Vatican City.Bottom row (L to R): Cardinal Peter Turkson (incoming chancellor of the PAS), Prof. Deepak Srivastava, Prof. Elly Tanaka, Prof. Helen M. Blau, Cardinal Marcelo Sánchez Sorondo (outgoing Chancellor of the Pontifical Academy of Sciences (Vatican City)), Prof. Catriona Jamieson, Prof. Joachim von Braun (President of the Pontifical Academy), Prof. Sean Morrison, Prof. Elaine FuchsTop row (L to R): Prof. George Q. Daley, Prof. Lorenz P. Studer, Prof. Alejandro Sánchez Alvarado, Prof. Hans Clevers, Prof. Jürgen Knoblich. Credit:Gabriella Clare Marino
Regions: Europe, Austria
Keywords: Science, Life Sciences, People in science

Testimonials

For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...


  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
Copyright 2022 by AlphaGalileo Terms Of Use Privacy Statement